Real-world safety and effectiveness of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Author:
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s00228-024-03720-7.pdf
Reference111 articles.
1. Liu GY, Budinger GRS, Dematte JE (2022) Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. BMJ (Clinical research ed) 377:e066354. https://doi.org/10.1136/bmj-2021-066354
2. Schäfer SC, Funke-Chambour M, Berezowska S (2020) Idiopathische Lungenfibrose – Epidemiologie Ursachen und klinischer Verlauf [Idiopathic pulmonary fibrosis-epidemiology causes, and clinical course]. Pathologe 41(1):46–51. https://doi.org/10.1007/s00292-019-00747-x
3. Maher TM, Bendstrup E, Dron L, Langley J, Smith G, Khalid JM, Patel H, Kreuter M (2021) Global incidence and prevalence of idiopathic pulmonary fibrosis. Respir Res 22(1):197. https://doi.org/10.1186/s12931-021-01791-z
4. Raghu G, Chen SY, Yeh WS, Maroni B, Li Q, Lee YC, Collard HR (2014) Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older incidence prevalence and survival 2001–11 The Lancet. Respir Med 2(7):566–572. https://doi.org/10.1016/S2213-2600(14)70101-8
5. Collard HR, Ryerson CJ, Corte TJ, Jenkins G, Kondoh Y, Lederer DJ et al (2016) Acute Exacerbation of Idiopathic Pulmonary Fibrosis An International Working Group Report. Am J Respir Crit Care Med 194(3):265–275. https://doi.org/10.1164/rccm.201604-0801CI
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3